Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation
NCT04739930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2023-01-13
Summary
The goal of this study is to establish if mesenchymal stem cell augmentation improves graft incorporation and to analyze the cytokine environment of the joint after osteochondral allograft transplantation (OCA) with and without intra-articular bone marrow aspirate concentrate (BMAC) injection. Information learned from this study can be used to biochemically compare treatment response and to assess emerging therapeutic options that may positively alter the biochemical environment in patients who suffer from articular cartilage disorders.
Conditions
- Cartilage Injury
Interventions
- PROCEDURE
-
Autologous bone marrow aspirate will be harvested and concentrated to a bone marrow aspirate concentrate (BMAC) containing bone marrow derived mesenchymal stem cells and delivered to site of operation
Autologous bone marrow aspirate will be processed and concentrated to a bone marrow aspirate concentrate (BMAC) containing bone marrow derived mesenchymal stem cells and delivered to the site of operation in the treatment group
- PROCEDURE
-
Control group incision
0.5cm sham incision over the iliac crest
Sponsors & Collaborators
-
Joint Restoration Foundation
collaborator OTHER -
Rush University Medical Center
lead OTHER
Principal Investigators
-
Adam Yanke, MD · Faculty
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-02
- Primary Completion
- 2023-01-12
- Completion
- 2023-01-12
Countries
- United States
Study Locations
More Related Trials
-
Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis
NCT01931007 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stem Cells in Knee Cartilage Injuries
NCT02118519 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis
NCT03602872 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis
NCT02838069 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
NCT02003131 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis
NCT03337243 ·Status: COMPLETED ·Phase: NA
-
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy
NCT05933434 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair
NCT01895413 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Knee Osteoarthritis Treatment With Percutaneous Injections of Autologous Bone Marrow Concentrate
NCT04310852 ·Status: UNKNOWN
-
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy
NCT06893302 ·Status: RECRUITING ·Phase: NA
-
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
NCT04893174 ·Status: UNKNOWN ·Phase: PHASE1
-
Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells
NCT02123368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee
NCT02958267 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Two Techniques for Articular Cartilage Repair: Cultured Chondrocytes Vs. Cultured BMAC
NCT01961973 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Treatment of Osteoarthritis of the Knee in the Form of Chondromalacia of the Articular Cartilage Treated in the Arthroscopic Technique With the Use of:Autogenous Transplantation of Fragmented Adipose Tissue,PRP GF,Mesenchymal Cells,Hyaluronic Acid-low Molecular Weight and Cross-linked
NCT07110402 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effectiveness of Combined Intra-articular and Intra-osseus Injection VS a Single Intra-articular Injection of Bone Marrow Concentrate
NCT03876795 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-articular Injection of MSCs in Treatment of Knee OA
NCT03028428 ·Status: UNKNOWN ·Phase: PHASE2
-
Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis
NCT02805855 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
NCT06084988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy
NCT02827851 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
NCT06828666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study
NCT03110666 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
NCT02237846 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis
NCT01809769 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intra-articular Injection of UC-MSC Exosome in Knee Osteoarthritis
NCT06431152 ·Status: RECRUITING ·Phase: EARLY_PHASE1